...&D Systems adds two new Stem Cell Antibody Panels ...uman Embryonic Stem Cell Marker Antibody Panel (Ca...kaline phosphatase, Nanog, Oct-3/4, SSEA-1 and SSE... Panel Plus (Catalog # SC009) contains antibodies ...
Anti-Epstein-Barr Virus (EBV) (EBNA-1) Polyclonal Antibody, Biotin Conjugated from ViroStat Inc.
Rabbit Anti-ECE-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Rat Anti-Mouse HAI-1 Ectodomain Monoclonal Antibody, Unconjugated, Clone 199732 from R&D Systems
Biology Products:...What do the countries of Thailand, Uruguay and Gha...roducers of the emerging renewable fuel known as b...onsin-Madison Nelson Institute for Environmental S...m vegetable oils and animal fats has made it one o...ssil fuels. Seeking to understand which nations ar...
... Professor Laurette Dub, James McGill Chair in Con...convened an annual Health Challenge Think Tank bas...ealth issues in a comprehensive, effective way dem...s and areas of expertise. To that end, this years ...ientists, stakeholders and decision-makers, includ...
...as--Changes in the expression of genes may be the ...ay paint or glue, quickly develop a tolerance, bio...discovered. , The team, led by graduate student ...er as a model system to determine how the nervous ...olvent inhalants. , The team,s work appears in th...
Other Biology News:Researchers examine world's potential to produce biodiesel 2Researchers examine world's potential to produce biodiesel 3Changing the global dietary environment 2Tolerance to inhalants may be caused by changes in gene expression 2(Date:11/19/2009)...ire/ -- Dr. Mate Hidvegi, inventor of Avemar ferme...se issued on November 17 by Biropharma Kft, discre...self-serving statements about its U.S. competitor ...om his office in Budapest, Hungary: ,, "The Bi...ply to AveULTRA, www.aveultra.com , is misleadi...
(Date:11/19/2009)...rstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), anno...to its shareholders, discussing the Company,s acqu...uticals Holdings, Inc. (CHBP), an integrated bio-p...ic of China. The merger gives NeoStem a controllin...td., CHBP,s primary operating subsidiary and a pro...
(Date:11/19/2009)...ss., Nov. 19 Arlington Medical Res...leading driver of antibiotic selection in nosocomi...against gram-positive and gram-negative pathogens....socomial pneumonia, surveyed European physicians r...vide appropriate coverage against common pathogens...
(Date:11/19/2009)... Aegera Therapeutics Inc. announced today the dosi...tudy of AEG35156, a targeted antisense therapeutic...dications. ,, The study, entitled "An Open-Labe...or of Apoptosis (XIAP) Antisense AEG35156 Given in...cin in AML Following Failure of a Single Standard ...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2